<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02826473</url>
  </required_header>
  <id_info>
    <org_study_id>LUKS-2016-00140</org_study_id>
    <secondary_id>2016-00140</secondary_id>
    <nct_id>NCT02826473</nct_id>
  </id_info>
  <brief_title>Focused Cognitive Testing in Inpatients</brief_title>
  <acronym>FCTI</acronym>
  <official_title>Analysis of Clinical- and Cost-effectiveness of Focused Cognitive Testing in Elective Inpatients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Luzerner Kantonsspital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Lucerne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Luzerner Kantonsspital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neurocognitive Disorder (NCD) affects over 116'000 people in Switzerland and is frequently
      unrecognized and underdiagnosed. Because missed and delayed diagnosis are associated with an
      increased burden of disease health Service Research has prompted a discussion about
      diagnostic guidelines and screening programs. Some argue that screening for NCD in primary
      care is the optimal strategy to increase recognition rates; others consider test protocols
      implemented into hospital admission assessments as more justified. There is no distinct
      recommendation due to a lack of empirical data on the benefits and harms of cognitive testing
      yet. This trial strives to fill this gap and provide information about the benefits, harms
      and the economic case of routine cognitive testing for neurocognitive disorder in high risk
      elective inpatients, in Switzerland.

      The investigators hypothesize that, cognitive tested patients, compared with patients not
      cognitive tested, will have higher health-related quality of life at 12months; and lower
      medical health care costs at 18months.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">January 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Health related quality of life (HRQoL)</measure>
    <time_frame>every month during 18months</time_frame>
    <description>Patient and Caregiver, using EuroQol 5D-5L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health Service Resource Utilization / Costs</measure>
    <time_frame>every month during 18months</time_frame>
    <description>Patient and Caregiver, using Resource Utilization in Dementia (RUD)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>prevalence of neurocognitive disorder</measure>
    <time_frame>baseline/6months</time_frame>
    <description>at Hospital admission</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>prevalence of risk factors associated with developing major neurocognitive disorder within 6 years</measure>
    <time_frame>baseline/6months</time_frame>
    <description>at Hospital Admission, using Brief Dementia Screening Indicator (BDSI)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>caregiver burden</measure>
    <time_frame>every 3 months</time_frame>
    <description>caregiver data, short Zarit Burden Interview (ZBI)</description>
  </other_outcome>
  <other_outcome>
    <measure>adverse events/adverse outcomes</measure>
    <time_frame>between baseline and 6months</time_frame>
    <description>falls, delirium, mortality, mortality within 30 days of discharge, re-admission within 18 days, institutionalization following hospitalization, length of stay</description>
  </other_outcome>
  <other_outcome>
    <measure>comorbidities</measure>
    <time_frame>baseline</time_frame>
    <description>patient data, using Charlson Comorbidity Index</description>
  </other_outcome>
  <other_outcome>
    <measure>neuropsychiatric symptoms</measure>
    <time_frame>between baseline and 6months</time_frame>
    <description>patient data during Hospital stay, using Neuropsychiatric Inventory Questionnaire (NPI-Q)</description>
  </other_outcome>
  <other_outcome>
    <measure>hospital anxiety and depression</measure>
    <time_frame>every 3 months</time_frame>
    <description>patient and caregiver data, using Hospital Anxiety and Depression Scale (HADS)</description>
  </other_outcome>
  <other_outcome>
    <measure>severity of cognitive impairment</measure>
    <time_frame>every 6 months</time_frame>
    <description>patients of the Intervention-Group will be assessed every months, using the Montreal Cognitive Assessment (MOCA)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Neurocognitive Disorders</condition>
  <arm_group>
    <arm_group_label>Intervention-Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control-Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>BRAINCHECK</intervention_name>
    <description>Subjects of the Intervention-Group will undergo a brief cognitive assessment, using the BRAINCHECK, during hospital admission assessments. Subjects with positive results will then be referred to a Memory Clinic undergoing subsequent interdisciplinary comprehensive diagnostic examinations. Patients with established diagnosis will be invited to counselling services of the Alzheimer Association (providing social counselling).</description>
    <arm_group_label>Intervention-Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective inpatients, living in the canton of lucerne, high risk of developing a major
             neurocognitive disorder, living at home

        Exclusion Criteria:

          -  Known mental disorder according to ICD-10, chapter V, excluding F32 &amp; F33, patients
             with terminal illness, patients of intensive care unit or oncology patients, no
             adequate vision or hearing, no ability to speak, write or to understand German, no
             Informant, antidementia medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Boes, Prof.Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Lucerne,Department of Health Sciences &amp; Health Policy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thomas Nyffeler, Prof.Dr.med.</last_name>
    <role>Study Chair</role>
    <affiliation>Cantonal Hospital of Lucerne</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aljoscha Benjamin, M.A. (HSG)</last_name>
    <role>Study Chair</role>
    <affiliation>Cantonal Hospital of Lucerne</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aljoscha Hwang, M.A. (HSG)</last_name>
    <phone>0041 (0) 41 205 4287</phone>
    <email>Aljoscha.Hwang@luks.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefan Boes, Prof.Dr</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cantonal Hospital of Lucerne</name>
      <address>
        <city>Lucerne</city>
        <state>Canton Lucerne</state>
        <zip>6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aljoscha Hwang, M.A. (HSG)</last_name>
      <phone>0041 (0) 41 205 4287</phone>
      <email>Aljoscha.Hwang@luks.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2016</study_first_submitted>
  <study_first_submitted_qc>July 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 11, 2016</study_first_posted>
  <last_update_submitted>August 31, 2017</last_update_submitted>
  <last_update_submitted_qc>August 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Luzerner Kantonsspital</investigator_affiliation>
    <investigator_full_name>Aljoscha Hwang</investigator_full_name>
    <investigator_title>Health Research Manager</investigator_title>
  </responsible_party>
  <keyword>Dementia</keyword>
  <keyword>Dementia screening</keyword>
  <keyword>General Hospital</keyword>
  <keyword>Inpatients</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neurocognitive Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

